ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Psychiatry

Top Psychiatry Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
EDUARDO RUEDA VASQUEZ MD

Psychiatry

529

$85.1K

34
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 22%

$161
Average prescription price

Avg: $115

DANIEL WOLF M.D., PH.D.

Psychiatry

528

$80.5K

48
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 22%

$152
Average prescription price

Avg: $115

BRIAN BORA M.D.

Psychiatry

524

$64.8K

54
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 22%

$124
Average prescription price

Avg: $115

MICHAEL TURK M.D.

Psychiatry

516

$88.9K

28
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

34%
prescriptions for brand name drugs

Avg: 22%

$172
Average prescription price

Avg: $115

SOOK YOO MD

Psychiatry

512

$12.6K

90
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

10%
prescriptions for brand name drugs

Avg: 22%

$25
Average prescription price

Avg: $115

JOHN TUMEH M.D.

Psychiatry

511

$51.7K

28
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

13%
prescriptions for brand name drugs

Avg: 22%

$101
Average prescription price

Avg: $115

MARY KUSH M.D.

Psychiatry

507

$56.3K

32
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 22%

$111
Average prescription price

Avg: $115

FEREYDOON RADFAR MD

Psychiatry

502

$49.7K

66
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 22%

$99
Average prescription price

Avg: $115

SANDY MELNICK MD

Psychiatry

499

$42.5K

84
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 22%

$85
Average prescription price

Avg: $115

MOHAMED DATTU M.D.

Psychiatry

499

$42.7K

59
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 22%

$86
Average prescription price

Avg: $115

DENNIS DONNELLY M.D.

Psychiatry

498

$27.7K

48
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

13%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $115

EDGAR GANTALAO M.D.

Psychiatry

493

$42.9K

46
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 22%

$87
Average prescription price

Avg: $115

STEVEN ARNOLD MD

Psychiatry

486

$35.8K

75
64 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 22%

$74
Average prescription price

Avg: $115

JOHN BROOKS MD

Psychiatry

483

$53.3K

32
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 22%

$110
Average prescription price

Avg: $115

SERMSAK LOLAK MD

Psychiatry

478

$64.3K

37
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 22%

$135
Average prescription price

Avg: $115

MICHELLE BARWELL M.D.

Psychiatry

476

$52.4K

33
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 22%

$110
Average prescription price

Avg: $115

MOHAMMAD HAMEED MD

Psychiatry

474

$55.5K

77
13 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

17%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 22%

$117
Average prescription price

Avg: $115

MANISHA KAMAT MD

Psychiatry

471

$35.2K

40
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 22%

$75
Average prescription price

Avg: $115

RAIHANA BEG M.D.

Psychiatry

465

$67.5K

31
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

38%
prescriptions for brand name drugs

Avg: 22%

$145
Average prescription price

Avg: $115

VERNON NATHANIEL

Psychiatry

462

$100K

25
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 22%

$217
Average prescription price

Avg: $115

ABAYOMI IGE M.D.

Psychiatry

459

$65.9K

56
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 22%

$144
Average prescription price

Avg: $115

DENNIS DOMBROWSKI MD

Psychiatry

450

$30.4K

80
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

10%
prescriptions for brand name drugs

Avg: 22%

$67
Average prescription price

Avg: $115

KAVITA BHARWANI M.D.

Psychiatry

445

$8,550

66
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

10%
prescriptions for brand name drugs

Avg: 22%

$19
Average prescription price

Avg: $115

VITASTA BAZAZ MD MPH

Psychiatry

441

$40.4K

36
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 22%

$92
Average prescription price

Avg: $115

JOHN MARTYNIUK PHD., M.D.

Psychiatry

436

$45.5K

23
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

8%
prescriptions for brand name drugs

Avg: 22%

$104
Average prescription price

Avg: $115

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank